OTCMKTS:CNBX

CNBX Pharmaceuticals Stock Competitors

$7.35

+0.04 (+0.55%)

(As of 05/20/2022 12:00 AM ET)

Add

Compare

Today's Range: $7.35
▼
$7.35
50-Day Range: $6.76
▼
$10.56
52-Week Range: $0.06
▼
$0.23

Volume: 360 shs
Average Volume: 106,408 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Beta: N/A

CNBX Pharmaceuticals (OTCMKTS:CNBX) Vs. IIPR, MSRT, GRWG, XXII, KSHB, NSAV, CANN, TRTC, PVSP, and NMUS

Should you be buying CNBX Pharmaceuticals stock or one of its competitors? The main competitors of CNBX Pharmaceuticals include Innovative Industrial Properties (IIPR), MassRoots (MSRT), GrowGeneration (GRWG), 22nd Century Group (XXII), KushCo (KSHB), Net Savings Link (NSAV), General Cannabis (CANN), Unrivaled Brands (TRTC), Pervasip (PVSP), and Nemus Bioscience (NMUS). These companies are all part of the "cannabis" industry.

CNBX Pharmaceuticals vs.

Innovative Industrial Properties (NYSE:IIPR) and CNBX Pharmaceuticals (OTCMKTS:CNBX) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, profitability, valuation, risk, community ranking, dividends and earnings.

: Innovative Industrial Properties received 183 more outperform votes than CNBX Pharmaceuticals when rated by MarketBeat users. Likewise, 61.97% of users gave Innovative Industrial Properties an outperform vote while only 60.26% of users gave CNBX Pharmaceuticals an outperform vote.
Company Underperform Outperform
Innovative Industrial Properties Outperform Votes
277
61.97%
Underperform Votes
170
38.03%
CNBX Pharmaceuticals Outperform Votes
94
60.26%
Underperform Votes
62
39.74%
: Innovative Industrial Properties has a net margin of 54.43% compared to CNBX Pharmaceuticals' net margin of 0.00%. Innovative Industrial Properties' return on equity of 7.91% beat CNBX Pharmaceuticals' return on equity.
Company Net Margins Return on Equity Return on Assets
Innovative Industrial Properties 54.43% 7.91% 5.87%
CNBX Pharmaceuticals N/A N/A N/A
: 66.9% of Innovative Industrial Properties shares are held by institutional investors. 1.5% of Innovative Industrial Properties shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
: In the previous week, Innovative Industrial Properties had 7 more articles in the media than CNBX Pharmaceuticals. MarketBeat recorded 8 mentions for Innovative Industrial Properties and 1 mentions for CNBX Pharmaceuticals. Innovative Industrial Properties' average media sentiment score of 0.60 beat CNBX Pharmaceuticals' score of 0.00 indicating that Innovative Industrial Properties is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Innovative Industrial Properties
2 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CNBX Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: Innovative Industrial Properties has higher revenue and earnings than CNBX Pharmaceuticals.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Innovative Industrial Properties $204.55 million 17.94 $113.99 million $4.83 27.17
CNBX Pharmaceuticals N/A N/A N/A N/A N/A
: Innovative Industrial Properties presently has a consensus price target of $257.33, suggesting a potential upside of 96.12%. Given Innovative Industrial Properties' higher possible upside, analysts plainly believe Innovative Industrial Properties is more favorable than CNBX Pharmaceuticals.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innovative Industrial Properties
0 Sell rating(s)

0 Hold rating(s)

5 Buy rating(s)

0 Strong Buy rating(s)
3.00
CNBX Pharmaceuticals
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A

Company	Underperform	Outperform
Innovative Industrial Properties	Outperform Votes 277 61.97%	Underperform Votes 170 38.03%
CNBX Pharmaceuticals	Outperform Votes 94 60.26%	Underperform Votes 62 39.74%

Company	Net Margins	Return on Equity	Return on Assets
Innovative Industrial Properties	54.43%	7.91%	5.87%
CNBX Pharmaceuticals	N/A	N/A	N/A

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Innovative Industrial Properties	2 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CNBX Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Innovative Industrial Properties	$204.55 million	17.94	$113.99 million	$4.83	27.17
CNBX Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Innovative Industrial Properties	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
CNBX Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Summary

Innovative Industrial Properties beats CNBX Pharmaceuticals on 12 of the 12 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of OTCMKTS and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CNBX Pharmaceuticals (OTCMKTS:CNBX) vs. Its Competitors

Export to Excel

Metric	CNBX Pharmaceuticals	Biotechnology Industry	Medical Sector	OTCMKTS Exchange
Market Cap	N/A	$212.87M	$4.32B	$6.86B
Dividend Yield	N/A	1.38%	2.02%	37.21%
P/E Ratio	N/A	8.66	9.07	1.96
Price / Sales	N/A	6,976.67	2,413.07	1,322.85
Price / Cash	N/A	13.34	22.92	25.99
Price / Book	N/A	5.27	4.03	4.22
Net Income	N/A	N/A	$164.30M	$721.83M
7 Day Performance	8.73%	-0.28%	1.10%	0.77%
1 Month Performance	-25.30%	-9.30%	-14.06%	-5.48%
1 Year Performance	-67.76%	11.81%	-31.00%	51.41%

CNBX Pharmaceuticals Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IIPR Innovative Industrial Properties	3.0681 of 5 stars	$131.21 +0.8%	$257.33 +96.1%	-24.9%	$3.67B	$204.55M	27.17	18	Short Interest ↑
MSRT MassRoots	1 of 5 stars	$5.20 -0.2%	N/A	-37.0%	$2.60B	$10K	0.00	3	News Coverage Gap Up
GRWG GrowGeneration	1.9926 of 5 stars	$5.06 -4.0%	$16.31 +222.4%	-87.0%	$320.12M	$422.49M	253.00	634
XXII 22nd Century Group	1.7581 of 5 stars	$1.79 +1.7%	$6.50 +263.1%	N/A	$289.58M	$30.95M	-7.78	76	Positive News Gap Up
KSHB KushCo	1.7731 of 5 stars	$0.70 flat	$2.00 +187.8%	-20.1%	$110.83M	$113.84M	-3.86	109	Gap Down High Trading Volume
NSAV Net Savings Link	0.6665 of 5 stars	$0.01 flat	N/A	+9.1%	$58.63M	N/A	0.00	1	News Coverage Positive News
CANN General Cannabis	1.1598 of 5 stars	$0.29 -5.6%	N/A	-58.8%	$28.11M	$5.93M	0.00	77	Gap Up
TRTC Unrivaled Brands	1.0581 of 5 stars	$0.09 flat	N/A	-61.0%	$20.16M	$14.29M	0.00	50
PVSP Pervasip	0.7465 of 5 stars	$0.00 -9.5%	N/A	-55.8%	$10.82M	N/A	0.00	3	Positive News Gap Down
NMUS Nemus Bioscience	1 of 5 stars	$0.05 flat	N/A	-64.6%	$6.03M	N/A	0.00	N/A	Gap Down

LBUY Leafbuyer Technologies	1.2664 of 5 stars	$0.05 flat	N/A	-59.2%	$4.71M	$2.67M	-1.33	29	Positive News Gap Down
CNAB United Cannabis	0.7998 of 5 stars	N/A	N/A	N/A	$1.55M	N/A	0.00	65	News Coverage Gap Down High Trading Volume
DIGP Digipath	1.0464 of 5 stars	$0.02 +1.1%	N/A	-54.8%	$1.44M	$2.50M	0.00	17	Gap Down
MNTR Mentor Capital	1.3115 of 5 stars	$0.05 -7.4%	N/A	-54.5%	$1.24M	$6.01M	-5.00	73	Positive News Gap Down
FWDG FutureWorld	0.8531 of 5 stars	N/A	N/A	N/A	$880K	N/A	0.00	8
GRWC Grow Capital	1.1598 of 5 stars	$0.00 flat	N/A	N/A	$50K	$2.37M	0.00	21	News Coverage
OPMZ 1PM Industries	0.8265 of 5 stars	N/A	N/A	N/A	$0.00	N/A	0.00	2
AQSP Acquired Sales	0.8265 of 5 stars	$3.71 flat	N/A	-18.5%	$0.00	N/A	0.00	46	News Coverage
AMMJ American Cannabis	0.9064 of 5 stars	$0.06 +0.2%	N/A	-71.4%	$0.00	N/A	0.00	9	Gap Down
ACAN AmeriCann	0.7998 of 5 stars	$0.37 0.0%	N/A	-67.3%	$0.00	N/A	0.00	3	Positive News Gap Down
CBDS Cannabis Sativa	0.8798 of 5 stars	$0.13 -7.1%	N/A	-73.8%	$0.00	N/A	0.00	12
CRWG CrowdGather	1.2664 of 5 stars	$0.01 flat	N/A	-48.7%	$0.00	N/A	0.00	3	Gap Up High Trading Volume
FRLF Freedom Leaf	0.9064 of 5 stars	N/A	N/A	N/A	$0.00	N/A	0.00	12	Gap Up
FUTL FutureLand	0.7731 of 5 stars	N/A	N/A	N/A	$0.00	N/A	0.00	3
GBLX GB Sciences	0.8798 of 5 stars	$0.03 flat	N/A	-40.4%	$0.00	N/A	0.00	16	News Coverage Gap Down
GRNH GreenGro Technologies	0.9598 of 5 stars	$0.01 flat	N/A	-69.9%	$0.00	N/A	0.00	N/A	Gap Down
HRVSF Harvest Health & Recreation	1 of 5 stars	$3.22 flat	N/A	-22.4%	$0.00	N/A	0.00	1,200	Gap Down
MCOA Marijuana Company of America	0.9331 of 5 stars	$0.00 +14.3%	N/A	-85.7%	$0.00	N/A	0.00	4
MJNA Medical Marijuana	0.9864 of 5 stars	$0.02 -0.6%	N/A	-60.2%	$0.00	N/A	0.00	91	Upcoming Earnings News Coverage
MDCN Medican Enterprises	0.9598 of 5 stars	$0.00 -50.0%	N/A	-90.0%	$0.00	N/A	0.00	3	News Coverage
MDCL Medicine Man Technologies	0.9331 of 5 stars	$1.42 -2.7%	N/A	-43.8%	$0.00	N/A	0.00	25
NCAP Northsight Capital	0.8798 of 5 stars	N/A	N/A	N/A	$0.00	N/A	0.00	3	Gap Up
NGBL Notis Global	0.9064 of 5 stars	N/A	N/A	N/A	$0.00	N/A	0.00	N/A	Gap Up High Trading Volume
OWCP OWC Pharmaceutical Research	0.9864 of 5 stars	$0.00 -50.0%	N/A	-98.9%	$0.00	N/A	0.00	9
PKPH Peak Pharmaceuticals	1 of 5 stars	$0.06 -17.0%	N/A	-49.1%	$0.00	N/A	0.00	1	Gap Up
SRNA Surna	0.9864 of 5 stars	$1.04 -9.6%	N/A	+1,603.7%	$0.00	N/A	0.00	27	Gap Up
MJLB Ultrack Systems	0.9864 of 5 stars	$0.02 -3.7%	N/A	-66.3%	$0.00	N/A	0.00	18	Gap Down
BUDZ WEED	1 of 5 stars	$0.18 -2.7%	N/A	-56.9%	$0.00	N/A	0.00	2	Short Interest ↑
ZDPY Zoned Properties	0.9864 of 5 stars	$0.76 -5.0%	N/A	+31.7%	$0.00	N/A	0.00	4	Gap Down
ZZLL ZZLL Information Technology	0.7998 of 5 stars	$0.50 -18.0%	N/A	+354.5%	$0.00	N/A	0.00	20	Gap Down

This page was last updated on 5/21/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

CNBX Pharmaceuticals Stock Competitors

CNBX Pharmaceuticals (OTCMKTS:CNBX) Vs. IIPR, MSRT, GRWG, XXII, KSHB, NSAV, CANN, TRTC, PVSP, and NMUS

CNBX Pharmaceuticals vs.

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNBX Pharmaceuticals (OTCMKTS:CNBX) vs. Its Competitors

CNBX Pharmaceuticals Competitors List

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources